{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:03:57Z","timestamp":1777860237853,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRS"],"published-print":{"date-parts":[[2015,12,30]]},"DOI":"10.3233\/jrs-150662","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T11:03:28Z","timestamp":1451991808000},"page":"191-199","source":"Crossref","is-referenced-by-count":7,"title":["High risk use of OTC NSAIDs and ASA in family medicine: A retrospective chart review"],"prefix":"10.1177","volume":"27","author":[{"given":"Kevin","family":"Hamilton","sequence":"first","affiliation":[{"name":"College of Pharmacy, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}]},{"given":"Christine","family":"Davis","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}]},{"given":"Jamie","family":"Falk","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}]},{"given":"Alex","family":"Singer","sequence":"additional","affiliation":[{"name":"College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}]},{"given":"Shawn","family":"Bugden","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}]}],"member":"179","reference":[{"key":"10.3233\/JRS-150662_ref1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0149-2918(02)80063-7","article-title":"Development of a List of Consensus-Approved Clinical Indicators of Preventable Drug-Related Morbidity in Older Adults","volume":"24","author":"Robertson","year":"2002","journal-title":"Clin Ther"},{"key":"10.3233\/JRS-150662_ref2","first-page":"1","article-title":"A pharmacist-led information technology intervention for medication errors (PINCER): A multicentre, cluster randomised, controlled trial and cost-effectiveness analysis","volume":"6736","author":"Avery","year":"2012","journal-title":"Lancet"},{"key":"10.3233\/JRS-150662_ref3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2125.2009.03531.x","article-title":"Potentially inappropriate prescribing in an Irish elderly population in primary care","volume":"68","author":"Ryan","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JRS-150662_ref4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"60","author":"Fick","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JRS-150662_ref5","first-page":"2218","article-title":"Patterns of use and public perception of over-the-counter pain relievers: Focus on nonsteroidal antiinflammatory drugs","volume":"32","author":"Wilcox","year":"2005","journal-title":"J Rheumatol"},{"key":"10.3233\/JRS-150662_ref6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JRS-150662_ref7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","article-title":"Incidence of fatal adverse drug reactions: A population based study","volume":"65","author":"Wester","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JRS-150662_ref8","first-page":"217","article-title":"Medication-related emergency department visits and hospitalizations among older adults","volume":"60","author":"Bayoumi","year":"2014","journal-title":"Can Fam Physician.e"},{"key":"10.3233\/JRS-150662_ref9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/11596000-000000000-00000","article-title":"Targeting outpatient drug safety: Recommendations of the dutch HARM-Wrestling task force","volume":"35","author":"Warl\u00e9-Van Herwaarden","year":"2012","journal-title":"Drug Saf"},{"key":"10.3233\/JRS-150662_ref10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00228-009-0641-8","article-title":"Regional surveillance of emergency-department visits for outpatient adverse drug events","volume":"65","author":"Capuano","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JRS-150662_ref11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pds.3362","article-title":"Absence of \u201cover-the-counter\u201d medicinal products in on-line prescription records: A risk factor of overlooking interactions in the elderly","volume":"22","author":"Olesen","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"10.3233\/JRS-150662_ref12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1331\/JAPhA.2012.10123","article-title":"Identifying discrepancies in electronic medical records through pharmacist medication reconciliation","volume":"52","author":"Stewart","year":"2012","journal-title":"J Am Pharm Assoc"},{"key":"10.3233\/JRS-150662_ref13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person\u2019s Prescriptions) andSTART (Screening Tool to Alert doctors to Right Treatment)","volume":"46","author":"Gallagher","year":"2008","journal-title":"Consensus validation. Int J Clin Pharmacol Ther"},{"key":"10.3233\/JRS-150662_ref14","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis,9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.3233\/JRS-150662_ref15","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"10.3233\/JRS-150662_ref16","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am JGastroenterol"},{"key":"10.3233\/JRS-150662_ref17","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Anat. Ther. Chem. classification Syst. last Updat. March 25,2011."},{"key":"10.3233\/JRS-150662_ref18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jclinepi.2003.09.016","article-title":"An adaptation of Charlson comorbidity index predicted subsequent mortality in a health survey","volume":"57","author":"Rius","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JRS-150662_ref19","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.3399\/bjgp14X677815","article-title":"High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: A population-based cross-sectional study","volume":"64","author":"Koffeman","year":"2014","journal-title":"Br J Gen Pract"},{"key":"10.3233\/JRS-150662_ref20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archinte.165.2.189","article-title":"Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors","volume":"165","author":"Battistella","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.3233\/JRS-150662_ref21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.3233\/JRS-150662_ref22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamainternmed.2014.5398","article-title":"Risk of Bleeding With Dabigatran in Atrial Fibrillation","volume":"175","author":"Hernandez","year":"2015","journal-title":"JAMA Intern Med"}],"container-title":["International Journal of Risk & Safety in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JRS-150662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:44:43Z","timestamp":1777509883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JRS-150662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":22,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jrs-150662","relation":{},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}